Display Settings:

Format
Items per page

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 29

1.

Head & Shoulders brand of selenium disulfide

MedGen UID:
280641
Concept ID:
C1531398
Pharmacologic Substance
2.

Cisplatin

An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition. [from NCI]

MedGen UID:
40318
Concept ID:
C0008838
Pharmacologic Substance
3.

Malignant neoplastic disease

A general term for autonomous tissue growth exhibiting morphologic features of malignancy (e.g. severe atypia, nuclear pleomorphism, tumor cell necrosis, abnormal mitoses, tissue invasiveness) and for which the transformed cell type has not been specifically identified. [from NCI]

MedGen UID:
14297
Concept ID:
C0006826
Neoplastic Process
4.

Neoplasm of head and neck

A neoplasm of the head and neck region with origin in the lip, oral cavity, nasal cavity, paranasal sinuses, pharynx, and larynx. [from HPO]

MedGen UID:
501086
Concept ID:
CN168964
Finding
5.

MedGen UID:
108579
Concept ID:
C0596402
6.

pifithrin

MedGen UID:
212772
Concept ID:
C0909264
Pharmacologic Substance
7.

MedGen UID:
177938
Concept ID:
C0909265
8.

Visual Suppression

MedGen UID:
526147
Concept ID:
C0221103
Pathologic Function
9.

Spondylometaepiphyseal dysplasia short limb-hand type

MedGen UID:
338595
Concept ID:
C1849011
Disease or Syndrome
10.

Disease Response

The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression. [from NCI]

MedGen UID:
309976
Concept ID:
C1704632
Finding
11.

The psychological or physiological need to take a substance in oder to experience its effects or to avoid the effects of its absence. [from NCI]

MedGen UID:
141006
Concept ID:
C0439857
12.

Inhibition

MedGen UID:
5809
Concept ID:
C0021469
Molecular Function
13.

MedGen UID:
195927
Concept ID:
C0699666
14.

MedGen UID:
181696
Concept ID:
C0936226
15.

MedGen UID:
152100
Concept ID:
C0699665
16.

MedGen UID:
152099
Concept ID:
C0699664
17.

MedGen UID:
152098
Concept ID:
C0699663
18.

A change in the way a drug acts in the body when taken with certain other drugs, herbals, or foods, or when taken with certain medical conditions. Drug interactions may cause the drug to be more or less effective, or cause effects on the body that are not expected. [from NCI]

MedGen UID:
146913
Concept ID:
C0687133
19.

MedGen UID:
108834
Concept ID:
C0591833
20.

Endopeptidases

nonEC category which corresponds to EC 3.4.21, EC 3.4.22, EC 3.4.23, EC 3.4.24, and EC 3.4.99. [from CRISP]

MedGen UID:
45389
Concept ID:
C0030946
Pharmacologic Substance

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...